المؤلفون: Grall-Bronnec, Marie, Victorri-Vigneau, Caroline, Donnio, Yann, Leboucher, Juliette, Rousselet, Morgane, Thiabaud, Elsa, Zreika, Nicolas, Derkinderen, Pascal, Challet-Bouju, Gaëlle

المساهمون: Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), MethodS in Patients-centered outcomes and HEalth ResEarch (SPHERE), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques, Université de Nantes (UN)-Université de Nantes (UN), Centre d'évaluation et d'information sur la pharmacodépendance-addictovigilance CHU de Nantes (CEIP-A), The Enteric Nervous System in gut and brain disorders U1235 (TENS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)

المصدر: ISSN: 0114-5916 ; Drug Safety ; https://hal.science/hal-03158613 ; Drug Safety, 2018, 41 (1), pp.19-75. ⟨10.1007/s40264-017-0590-6⟩.

مصطلحات موضوعية: Parkinson Disease/drug therapy, Prevalence, Prolactinoma, Prolactinoma/drug therapy, Restless Legs Syndrome, Restless Legs Syndrome/drug therapy, Review, Risk Factors, Databases, Factual, Disruptive, Impulse Control, and Conduct Disorders, and Conduct Disorders/*chemically induced, Dopamine Agonists, Dopamine Agonists/*adverse effects, Drug-Related Side Effects and Adverse Reactions, Humans, Parkinson Disease, [SDV]Life Sciences [q-bio]

Relation: info:eu-repo/semantics/altIdentifier/pmid/28861870; PUBMED: 28861870; PUBMEDCENTRAL: PMC5762774

الاتاحة: https://hal.science/hal-03158613
https://hal.science/hal-03158613v1/document
https://hal.science/hal-03158613v1/file/s40264-017-0590-6-1.pdf
https://doi.org/10.1007/s40264-017-0590-6

المؤلفون: Anonymous

المصدر: Information från Läkemedelsverket. 16(5):37

المؤلفون: Grandgenevre, Pierre, Warembourg, Frederique, Carriere, Nicolas, Vaillant, Alexandra, DEFEBVRE, Luc, Vaiva, Guillaume

المساهمون: CHU Lille, CNRS, Inserm, Université de Lille, Troubles cognitifs dégénératifs et vasculaires - U 1171 TCDV, Troubles cognitifs dégénératifs et vasculaires - U1171, Sciences Cognitives et Sciences Affectives (SCALab) - UMR 9193, 462133, Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 SCALab, Service de neurophysiologie clinique CHRU Lille, Service de Psychiatrie CHRU Lille

مصطلحات موضوعية: Mesh:Male, Mesh:Interviews as Topic, Mesh:Humans, Mesh:Disruptive, Mesh:Impulse Control, Mesh:and Conduct Disorders/therapy, Mesh:Female, Mesh:Sexual Dysfunction, Mesh:Physiological/therapy, Mesh:Physiological/diagnosis, Mesh:Physiological/chemically induced, Mesh:Sexual Behavior/drug effects, Mesh:Parkinson Disease/therapy, Mesh:Spouses*/psychology, Mesh:Aged, Mesh:Antiparkinson Agents/adverse effects, Mesh:Caregivers/psychology, Mesh:Decision Making, Mesh:and Conduct Disorders/chemically induced, Mesh:and Conduct Disorders/diagnosis, Mesh:Middle Aged

وصف الملف: application/octet-stream

Relation: Presse medicale (Paris, France . 1983); Presse Med.; http://hdl.handle.net/20.500.12210/16005

الاتاحة: https://hdl.handle.net/20.500.12210/16005

المؤلفون: Anne Sauvaget, L Gaboriau, François Etcheverrigaray, Fanny Perrouin, Caroline Victorri-Vigneau, Marie Grall-Bronnec, Pascale Jolliet, Pascal Derkinderen, Gaëlle Challet-Bouju, Juliette Leboucher

المساهمون: Centre hospitalier universitaire de Nantes (CHU Nantes), MethodS in Patients-centered outcomes and HEalth ResEarch (SPHERE), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques, Université de Nantes (UN)-Université de Nantes (UN), Service d'addictologie[CHU Nantes], Pharmacie [CHD Vendée], Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon, Neuropathies du système nerveux entérique et pathologies digestives, implication des cellules gliales entériques, Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Pharmacologie Clinique [CHU Nantes], Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques

المصدر: Journal of clinical psychopharmacology
Journal of clinical psychopharmacology, 2016, 36 (1), pp.63-70. ⟨10.1097/JCP.0000000000000444⟩

مصطلحات موضوعية: medicine.medical_specialty, Adolescent, Impulse control disorder, [SDV]Life Sciences [q-bio], Aripiprazole, Disruptive, Aripiprazole/*adverse effects/pharmacology, Review, Impulse Control, Gambling/*chemically induced, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Dopamine, Dopamine D2, Receptors, medicine, Humans, Pharmacology (medical), Risk factor, and Conduct Disorders/chemically induced, Psychiatry, Pathological, and Conduct Disorders, medicine.disease, respiratory tract diseases, 030227 psychiatry, 3. Good health, Psychiatry and Mental health, Dopamine Agonists/*adverse effects/pharmacology, Gambling, Dopamine Agonists, Gambling disorder, Dopamine D2/agonists, Psychology, 030217 neurology & neurosurgery, medicine.drug, Clinical psychology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b512530fff9362638802891c354fe861
https://doi.org/10.1097/jcp.0000000000000444

المؤلفون: Grall-Bronnec, Marie, Sauvaget, Anne, Perrouin, Fanny, Leboucher, Juliette, Etcheverrigaray, François, Challet-Bouju, Gaëlle, Gaboriau, Louise, Derkinderen, Pascal, Jolliet, Pascale, Victorri-Vigneau, Caroline

المساهمون: Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, F-44000 Nantes, France, MethodS in Patients-centered outcomes and HEalth ResEarch (SPHERE), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR des Sciences Pharmaceutiques et Biologiques (Nantes Univ - UFR Pharmacie), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Pharmacie CHD Vendée, Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon (CHD Vendée), Neuropathies du système nerveux entérique et pathologies digestives : implication des cellules gliales entériques, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Service de Pharmacologie Clinique Nantes, Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)

المصدر: Journal of clinical psychopharmacology ; https://hal.science/hal-03157735 ; Journal of clinical psychopharmacology, 2016, 36 (1), pp.63-70. ⟨10.1097/JCP.0000000000000444⟩

مصطلحات موضوعية: Adolescent, Aripiprazole, Aripiprazole/*adverse effects/pharmacology, Disruptive, Impulse Control, and Conduct Disorders, and Conduct Disorders/chemically induced, Dopamine Agonists, Dopamine Agonists/*adverse effects/pharmacology, Gambling, Gambling/*chemically induced, Humans, Receptors, Dopamine D2, Dopamine D2/agonists, Review, Risk Factors, [SDV]Life Sciences [q-bio]

Relation: hal-03157735; https://hal.science/hal-03157735; PUBMEDCENTRAL: PMC4700874

الاتاحة: https://hal.science/hal-03157735
https://doi.org/10.1097/JCP.0000000000000444